Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer
Clinical trial NCT02594371 · COMPLETED
Trial details
- NCT number
- NCT02594371
- Sponsor
- Athenex, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-02
- Primary completion
- 2019-07-25
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.